시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 CRISPR 및 Cas 유전자 시장 보고서(2025년)
CRISPR And Cas Gene Global Market Report 2025
상품코드 : 1824630
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,430,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,294,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,159,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세계의 CRISPR 및 Cas 유전자 시장 규모는 향후 수년간 비약적인 성장이 예상됩니다. 2029년 연평균 복합 성장률(CAGR)은 22.0%로 확대되어 106억 7,000만 달러로 성장할 것으로 예상됩니다. 예측기간의 성장은 금지사항의 세계적 확대, 의식적 소비주의 증가, 새로운 브랜드의 출현, 소비자 교육의 노력, 미용의 포괄성에 기인한다고 생각됩니다. 예측기간의 주요 동향에는 기술 진보, 제품 혁신, 순환형 미용 경제, 남성용 그루밍 부문, 사회 정의, 윤리적 조달 등이 포함됩니다.

향후 5년간의 성장률 22.0%라는 예측은 지난 예측으로부터 0.2% 소폭 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 관세의 부과는 핀란드와 캐나다에서 수입되는 CRISPR-Cas9 유전자 편집 도구 및 시약에 대한 접근을 제한하고, 생물의료의 돌파구를 늦추고, 연구개발(R&D) 예산을 증가시킬 수 있기 때문에 미국의 연구에 중대한 문제 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향이 보다 광범위하게 이어질 수 있습니다.

개인화 치료에 대한 관심이 높아질 것으로 예상되며, 향후 CRISPR 및 Cas 유전자 시장의 성장을 이끌 것으로 예측됩니다. 맞춤형 치료에서는 개인의 유전자 프로파일을 활용하여 질병의 진단, 치료, 예방에 관한 의사결정을 실시했습니다. CRISPR 및 Cas 유전자, 특히 Cas9는 개인의 유전 물질에 대한 정확한 변경을 가능하게 함으로써, 맞춤형 의료에서 매우 중요한 역할을 하고 있으며, 유전성 질환, 암, 다양한 병리에 대한 맞춤형 치료에 획기적인 진보를 가져올 수 있습니다. 예를 들어 미국을 기반으로 한 전문가 회원 조직인 Personalized Medicine Coalition의 데이터에 따르면 2022년 식품의약국(FDA)의 의약품평가연구센터(CDER)는 37개의 신규분자화합물(NME)을 승인했습니다. 이 중 약 34%에 해당하는 12개 품목은 맞춤형 의료연합(PMC)에 의해 개별화 의약품으로 분류되어 있습니다. 따라서 개인화 치료에 대한 수요 증가는 CRISPR 및 Cas 유전자 시장의 성장을 가속할 것으로 예측됩니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 전략

제36장 부록

JHS
영문 목차

영문목차

CRISPR, or Clustered Regularly Interspaced Short Palindromic Repeats, along with the Cas (CRISPR-associated) gene, particularly Cas9, represents a powerful gene-editing technology. This system enables precise modifications to DNA sequences, revolutionizing genetic research, biotechnology, and potential medical applications.

The primary product types within the CRISPR and Cas genes market include kits and enzymes, libraries, design tools, antibodies, and others. Kits and enzymes are fundamental components in the realm of CRISPR-based gene therapy, with kits containing the necessary ingredients and instruments for gene editing research, and enzymes, such as Cas9, playing a pivotal role in the gene editing process. Services are categorized into cell line engineering, gRNA design, microbial gene editing, and DNA synthesis, and find applications across clinical, financial, operational, and administrative domains. End users of these products and services include biotechnology and pharmaceutical companies, academic and government research institutes, as well as contract research organizations (CROs).

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The CRISPR and Cas gene research report is one of a series of new reports from The Business Research Company that provides CRISPR and Cas gene market statistics, including the CRISPR and Cas gene industry's global market size, regional shares, competitors with a CRISPR and Cas gene market share, detailed CRISPR and Cas gene market segments, market trends and opportunities, and any further data you may need to thrive in the CRISPR and Cas gene industry. This CRISPR and Cas gene market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The crispr and cas gene market size has grown exponentially in recent years. It will grow from $3.99 billion in 2024 to $4.81 billion in 2025 at a compound annual growth rate (CAGR) of 20.8%. The growth in the historic period can be attributed to increased consumer awareness, shift in consumer values, rise in celebrity endorsements, rise of veganism, increased social media influence.

The crispr and cas gene market size is expected to see exponential growth in the next few years. It will grow to $10.67 billion in 2029 at a compound annual growth rate (CAGR) of 22.0%. The growth in the forecast period can be attributed to global expansion of bans, rising conscious consumerism, emergence of new brands, consumer education initiatives, beauty inclusivity. Major trends in the forecast period include technology advancements, product innovations, circular beauty economy, men's grooming segment, social justice and ethical sourcing.

The forecast of 22.0% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may pose a significant challenge for U.S. research by restricting access to Clustered Regularly Interspaced Short Palindromic Repeats(CRISPR)-Cas9 gene-editing tools and reagents imported from Finland and Canada, potentially slowing biomedical breakthroughs and increasing research and development (R&D) budgets. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The anticipated increase in focus on personalized therapy is set to drive the growth of the CRISPR and Cas gene markets in the future. Personalized therapy involves utilizing an individual's genetic profile to inform decisions regarding disease diagnosis, treatment, and prevention. CRISPR and the Cas gene, particularly Cas9, play a pivotal role in personalized medicine by enabling precise modifications to an individual's genetic material, offering potential breakthroughs in tailored therapies for genetic disorders, cancer, and various medical conditions. For example, data from the Personalized Medicine Coalition, a US-based professional membership organization, revealed that in 2022, the Food and Drug Administration's Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs). Among these, approximately 34%, or 12 of them, are classified as personalized medicines by the Personalized Medicine Coalition (PMC). Thus, the growing demand for personalized therapy is expected to fuel the growth of the CRISPR and Cas gene markets.

Key players in the CRISPR and Cas gene markets are actively developing innovative products such as CRISPR-based cell-based gene therapy to enhance their product offerings and gain a competitive edge. CRISPR-based cell-based gene therapy involves utilizing CRISPR gene-editing technology to modify or correct genetic material within cells, presenting a targeted and potentially transformative approach to treating genetic disorders, diseases, and other medical conditions at the cellular level. For instance, in December 2023, Vertex Pharmaceuticals Incorporated, a US-based biopharmaceutical company, obtained approval from the U.S. Food and Drug Administration (FDA) for CASGEVY (exagamglogene autotemcel [exa-cel]). CASGEVY is a CRISPR/Cas9 genome-edited gene therapy indicated for managing sickle cell disease (SCD) in individuals aged 12 and above who experience recurrent vaso-occlusive crises. This first-of-its-kind therapy has the potential to offer a one-time transformative treatment for eligible sickle cell patients. Vertex is collaborating with experienced institutions to establish a network of approved treatment centers (ATCs) across the United States to administer CASGEVY to patients, requiring specific training in stem cell transplantation.

In January 2022, Bayer AG, a Germany-based pharmaceutical company, entered into a collaboration with Mammoth Biosciences to harness the natural richness in advancing the next generation of CRISPR products. This partnership aims to utilize Mammoth's CRISPR systems for developing in vivo gene-editing therapies, enhancing Bayer's emerging cell and gene therapy platform. The collaboration aligns with Mammoth Biosciences' goal of unlocking the full potential of innovative CRISPR systems. Mammoth BioSciences is a US-based biotechnology company specializing in developing CRISPR-Cas gene diagnostic tests.

Major companies operating in the Crispr and cas gene market report are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., AstraZeneca plc., Danaher Corporation, Quest Diagnostics, Lonza Group AG, Bio-Rad Laboratories Inc., eGenesis, Novartis Institutes for BioMedical Research, Myriad Genetics Inc., GenScript, Takara Bio Inc., 23andMe Inc., Merck KGaA, Color Genomics Inc., Horizon Discovery Group PLC, Beam Therapeutics Inc., Intellia Therapeutics Inc., New England BioLabs, Recursion Pharmaceuticals Inc., Caribou Biosciences Inc., Cellectis S.A., Editas Medicine Inc.

North America was the largest region in the CRISPR and Cas gene market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the crispr and cas gene market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the CRISPR and Cas gene market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The CRISPR and Cas gene market consists of revenues earned by entities by offering services such as gene editing, targeted disruption of genes, targeted drug development, livestock breeding, and animal model construction. The market value includes the value of related goods sold by the service provider or included within the service offering. The CRISPR and Cas gene market also includes sales of RNA clean-up kits, phenol-free kits, t7 polymerase mix, and RNAse-free water. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

CRISPR And Cas Gene Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on crispr and cas gene market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for crispr and cas gene ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The crispr and cas gene market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. CRISPR And Cas Gene Market Characteristics

3. CRISPR And Cas Gene Market Trends And Strategies

4. CRISPR And Cas Gene Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global CRISPR And Cas Gene Growth Analysis And Strategic Analysis Framework

6. CRISPR And Cas Gene Market Segmentation

7. CRISPR And Cas Gene Market Regional And Country Analysis

8. Asia-Pacific CRISPR And Cas Gene Market

9. China CRISPR And Cas Gene Market

10. India CRISPR And Cas Gene Market

11. Japan CRISPR And Cas Gene Market

12. Australia CRISPR And Cas Gene Market

13. Indonesia CRISPR And Cas Gene Market

14. South Korea CRISPR And Cas Gene Market

15. Western Europe CRISPR And Cas Gene Market

16. UK CRISPR And Cas Gene Market

17. Germany CRISPR And Cas Gene Market

18. France CRISPR And Cas Gene Market

19. Italy CRISPR And Cas Gene Market

20. Spain CRISPR And Cas Gene Market

21. Eastern Europe CRISPR And Cas Gene Market

22. Russia CRISPR And Cas Gene Market

23. North America CRISPR And Cas Gene Market

24. USA CRISPR And Cas Gene Market

25. Canada CRISPR And Cas Gene Market

26. South America CRISPR And Cas Gene Market

27. Brazil CRISPR And Cas Gene Market

28. Middle East CRISPR And Cas Gene Market

29. Africa CRISPR And Cas Gene Market

30. CRISPR And Cas Gene Market Competitive Landscape And Company Profiles

31. CRISPR And Cas Gene Market Other Major And Innovative Companies

32. Global CRISPR And Cas Gene Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The CRISPR And Cas Gene Market

34. Recent Developments In The CRISPR And Cas Gene Market

35. CRISPR And Cas Gene Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기